Chrysin serves as a novel inhibitor of DGKα/FAK interaction to suppress the malignancy of esophageal squamous cell carcinoma (ESCC)

Publication date: Available online 23 July 2020Source: Acta Pharmaceutica Sinica BAuthor(s): Jie Chen, Yan Wang, Di Zhao, Lingyuan Zhang, Weimin Zhang, Jiawen Fan, Jinting Li, Qimin Zhan
Source: Acta Pharmaceutica Sinica B - Category: Cancer & Oncology Source Type: research